Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.51 USD | -2.10% | +42.49% | +169.19% |
Apr. 29 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
Apr. 29 | Cullinan Therapeutics, Inc Appoints Mary Kay Fenton as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+169.19% | 1.21B | |
+25.90% | 42.68B | |
-3.90% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.67% | 24.94B | |
-21.62% | 18.96B | |
+27.75% | 12.3B | |
-2.96% | 11.95B | |
-1.88% | 11.55B |
- Stock Market
- Equities
- CGEM Stock
- News Cullinan Therapeutics, Inc.
- Cullinan Oncology : Morgan Stanley Adjusts Cullinan Oncology's Price Target to $43 From $40, Maintains Overweight Rating